Chang AB et al. |
Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. |
2012 |
Trials |
pmid:22937736
|
Pokharel S et al. |
Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. |
2017 |
Trials |
pmid:28969659
|
Noedl H |
ABC - antibiotics-based combinations for the treatment of severe malaria? |
2009 |
Trends Parasitol. |
pmid:19819757
|
|
Azithro once a week for MAC. |
1998 |
TreatmentUpdate |
pmid:11365625
|
|
Infection fighters. MAC prevention takes a holiday. |
2000 |
TreatmentUpdate |
pmid:12132450
|
|
What's in the water? |
1995 Mar-Apr |
Treat Rev |
pmid:11362299
|
Swanson RN et al. |
Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study. |
2005 |
Treat Respir Med |
pmid:15725048
|
Cymbala AA et al. |
The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. |
2005 |
Treat Respir Med |
pmid:15813663
|
Zervos M et al. |
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. |
2004 |
Treat Respir Med |
pmid:15606222
|
Requena-Méndez A et al. |
Enteric fever in Barcelona: Changing patterns of importation and antibiotic resistance. |
|
Travel Med Infect Dis |
pmid:27890811
|
Dave J et al. |
Trends in antibiotic susceptibility of enteric fever isolates in East London. |
|
Travel Med Infect Dis |
pmid:25964222
|
Baneke A |
Review: Targeting trachoma: Strategies to reduce the leading infectious cause of blindness. |
2012 |
Travel Med Infect Dis |
pmid:22326056
|
Nash MM and Zaltzman JS |
Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. |
1998 |
Transplantation |
pmid:9665078
|
Verleden GM and Dupont LJ |
Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. |
2004 |
Transplantation |
pmid:15167610
|
Imai N et al. |
A case of Campylobacter enteritis in a renal transplant recipient. |
2013 |
Transplantation |
pmid:23774778
|
Vos R et al. |
Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. |
2012 |
Transplantation |
pmid:22461039
|
Gottlieb J et al. |
Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. |
2008 |
Transplantation |
pmid:18192909
|
Verleden SE et al. |
Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? |
2013 |
Transplantation |
pmid:23425818
|
Wirnsberger GH and Pfragner R |
Comment on "Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients" by Nash and Zaltzman. |
1999 |
Transplantation |
pmid:10342326
|
Boran M et al. |
Improvement in cyclosporine A associated gingival hyperplasia with azithromycin therapy. |
1996 |
Transplant. Proc. |
pmid:8769234
|